IPRs Survive Supreme Court Scrutiny by Allowing USPTO Director to Review PTAB Decisions
The Supreme Court issued a decision today in U.S. v. Arthrex, Inc. upholding the use of inter partes reviews (IPRs) to challenge the validity…
Search our website:
The Supreme Court issued a decision today in U.S. v. Arthrex, Inc. upholding the use of inter partes reviews (IPRs) to challenge the validity…
The USPTO recently issued comments concerning the impact of the PTAB’s motion to amend (“MTA”) pilot program on AIA trials.…
The Patent Office recently launched a page for artificial intelligence information on its website. The page provides information on the…
Buchanan is proud to announce that our colleague Todd R. Walters was selected by his peers and named the Best Lawyers®…
Todd Walters will serve as a Vice Chair of IPO’s U.S. Post Grant Patent Office Practice Committee for calendar year…
The PTAB has published an update to the AIA Trial Practice Guide (TPG) containing additional guidance about trial practice before the…
Update: Perhaps recognizing that the decision uses overly broad language, the PTAB de-designated the Ex parte Jung decision on August…
Recently, the Patent Trial and Appeal Board (PTAB) issued guidance on the impact of SAS Institute Inc. v. Iancu on…
On Tuesday, September 12, 2017, the Patent Trial & Appeal Board (PTAB) conducted a special “Boardside Chat” webinar with Chief…
Patexia, an intellectual property (IP) company that performs analytical studies for IP-related issues, issued a report on June 14, 2017…
This article was reprinted with permission from Law360. For patents subject to pre-AIA 35 U.S.C. § 102, patent owners involved…
Recently, the Supreme Court agreed to hear arguments on the question of whether the PTAB is required to issue a…